Application of phosphoinositide-binding domains for the detection and quantification of specific phosphoinositides

Analytical Biochemistry

Volumn 355, Issue 1, 2006, Pages 8-18

  Furutani, Masahiro ^a,b   Tsujita, Kazuya ^a,b   Itoh, Toshiki ^a,b   Ijuin, Takeshi ^a,b   Takenawa, Tadaomi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

ELISA; FYVE finger domain; Phosphoinositide; PI 3 kinase; Pleckstrin homology domain; PTEN

Indexed keywords

CONTROLLED DRUG DELIVERY; DIAGNOSIS; ENZYME IMMOBILIZATION; LIPOSOMES; MAMMALS; METABOLISM; PHOSPHATASES; PHOSPHOLIPIDS;

ELISA; FYVE FINGER DOMAIN; PHOSPHOINOSITIDES; PLECKSTRIN HOMOLOGY DOMAINS; PTEN;

DISEASES;

ALKYL GROUP; LIPOSOME; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; PLECKSTRIN;

ARTICLE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; ENZYME IMMOBILIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SPECIFICITY; ENZYME SUBSTRATE; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

MAMMALIA;

EID: 33745926546     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2006.05.014     Document Type: Article

References (35)

1. Itoh T., and Takenawa T. Phosphoinositide-binding domains: functional units for temporal and spatial regulation of intracellular signalling. Cell. Signal. 14 (2002) 733-743
2. Czech M.P. Dynamics of phosphoinositides in membrane retrieval and insertion. Annu. Rev. Physiol. 65 (2003) 791-815
3. Lemmon M.A. Phosphoinositide recognition domains. Traffic 4 (2003) 201-213
4. Cullen P.J., Cozier G.E., Banting G., and Mellor H. Modular phosphoinositide-binding domains-their role in signalling and membrane trafficking. Curr. Biol. 11 (2001) R882-R893
5. Takenawa T., and Itoh T. Phosphoinositides, key molecules for regulation of actin cytoskeletal organization and membrane traffic from the plasma membrane. Biochim. Biophys. Acta 1533 (2001) 190-206
6. Janmey P.A., and Lindberg U. Cytoskeletal regulation: rich in lipids. Nat. Rev. Mol. Cell Biol. 5 (2004) 658-666
7. Ellson C.D., Andrews S., Stephens L.R., and Hawkins P.T. The PX domain: a new phosphoinositide-binding module. J. Cell Sci. 115 (2002) 1099-1105
8. Itoh T., Koshiba S., Kigawa T., Kikuchi A., Yokoyama S., and Takenawa T. Role of the ENTH domain in phosphatidylinositol-4,5-bisphosphate binding and endocytosis. Science 291 (2001) 1047-1051
9. Gillooly D.J., Simonsen A., and Stenmark H. Cellular functions of phosphatidylinositol 3-phosphate and FYVE domain proteins. Biochem. J. 355 (2001) 249-258
10. Hamada K., Shimizu T., Matsui T., Tsukita S., and Hakoshima T. Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J. 19 (2000) 4449-4462
11. Doerks T., Strauss M., Brendel M., and Bork P. GRAM, a novel domain in glucosyltransferases, myotubularins and other putative membrane-associated proteins. Trends Biochem. Sci. 25 (2000) 483-485
12. Varnai P., and Balla T. Visualization of phosphoinositides that bind pleckstrin homology domains: calcium- and agonist-induced dynamic changes and relationship to myo-[3H]inositol-labeled phosphoinositide pools. J. Cell Biol. 143 (1998) 501-510
13. Gray A., Van Der Kaay J., and Downes C.P. The pleckstrin homology domains of protein kinase B and GRP1 (general receptor for phosphoinositides-1) are sensitive and selective probes for the cellular detection of phosphatidylinositol 3,4-bisphosphate and/or phosphatidylinositol 3,4,5-trisphosphate in vivo. Biochem. J. 344 Pt 3 (1999) 929-936
14. Godi A., Di Campli A., Konstantakopoulos A., Di Tullio G., Alessi D.R., Kular G.S., Daniele T., Marra P., Lucocq J.M., and De Matteis M.A. FAPPs control Golgi-to-cell-surface membrane traffic by binding to ARF and PtdIns(4)P. Nat. Cell Biol. 6 (2004) 393-404
15. Dowler S., Currie R.A., Campbell D.G., Deak M., Kular G., Downes C.P., and Alessi D.R. Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochem. J. 351 (2000) 19-31
16. Berger P., Schaffitzel C., Berger I., Ban N., and Suter U. Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module. Proc. Natl. Acad. Sci. USA 100 (2003) 12177-12182
17. Tsujita K., Itoh T., Ijuin T., Yamamoto A., Shisheva A., Laporte J., and Takenawa T. Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction. J. Biol. Chem. 279 (2004) 13817-13824
18. Pendaries C., Tronchere H., Plantavid M., and Payrastre B. Phosphoinositide signaling disorders in human diseases. FEBS Lett. 546 (2003) 25-31
19. Cantley L.C., and Neel B.G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA 96 (1999) 4240-4245
20. Leslie N.R., and Downes C.P. PTEN: the down side of PI 3-kinase signalling. Cell. Signal. 14 (2002) 285-295
21. Sleeman M.W., Wortley K.E., Lai K.M., Gowen L.C., Kintner J., Kline W.O., Garcia K., Stitt T.N., Yancopoulos G.D., Wiegand S.J., and Glass D.J. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat. Med. 11 (2005) 199-205
22. Maehama T., Taylor G.S., Slama J.T., and Dixon J.E. A sensitive assay for phosphoinositide phosphatases. Anal. Biochem. 279 (2000) 248-250
23. Gillooly D.J., Morrow I.C., Lindsay M., Gould R., Bryant N.J., Gaullier J.M., Parton R.G., and Stenmark H. Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J. 19 (2000) 4577-4588
24. Lee J.O., Yang H., Georgescu M.M., Di Cristofano A., Maehama T., Shi Y., Dixon J.E., Pandolfi P., and Pavletich N.P. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99 (1999) 323-334
25. Meier T.I., Cook J.A., Thomas J.E., Radding J.A., Horn C., Lingaraj T., and Smith M.C. Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms. Protein Expr. Purif. 35 (2004) 218-224
26. Oikawa T., Yamaguchi H., Itoh T., Kato M., Ijuin T., Yamazaki D., Suetsugu S., and Takenawa T. PtdIns(3,4,5)P3 binding is necessary for WAVE2-induced formation of lamellipodia. Nat. Cell Biol. 6 (2004) 420-426
27. Kalb E., Frey S., and Tamm L.K. Formation of supported planar bilayers by fusion of vesicles to supported phospholipid monolayers. Biochim. Biophys. Acta 1103 (1992) 307-316
28. Iijima M., Huang Y.E., Luo H.R., Vazquez F., and Devreotes P.N. Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxis. J. Biol. Chem. 279 (2004) 16606-16613
29. Pirola L., Zvelebil M.J., Bulgarelli-Leva G., Van Obberghen E., Waterfield M.D., and Wymann M.P. Activation loop sequences confer substrate specificity to phosphoinositide 3-kinase alpha (PI3Kalpha). Functions of lipid kinase-deficient PI3Kalpha in signaling. J. Biol. Chem. 276 (2001) 21544-21554
30. Walker E.H., Pacold M.E., Perisic O., Stephens L., Hawkins P.T., Wymann M.P., and Williams R.L. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol. Cell 6 (2000) 909-919
31. Fidler I.J. Selection of successive tumour lines for metastasis. Nat. New Biol. 242 (1973) 148-149
32. Wei Y.J., Sun H.Q., Yamamoto M., Wlodarski P., Kunii K., Martinez M., Barylko B., Albanesi J.P., and Yin H.L. Type II phosphatidylinositol 4-kinase beta is a cytosolic and peripheral membrane protein that is recruited to the plasma membrane and activated by Rac-GTP. J. Biol. Chem. 277 (2002) 46586-46593
33. Kurisu S., Suetsugu S., Yamazaki D., Yamaguchi H., and Takenawa T. Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene 24 (2005) 1309-1319
34. Campbell I.G., Russell S.E., Choong D.Y., Montgomery K.G., Ciavarella M.L., Hooi C.S., Cristiano B.E., Pearson R.B., and Phillips W.A. Mutation of the PIK3CA gene in ovarian and breast cancer. Cancer Res. 64 (2004) 7678-7681
35. Bachman K.E., Argani P., Samuels Y., Silliman N., Ptak J., Szabo S., Konishi H., Karakas B., Blair B.G., Lin C., Peters B.A., Velculescu V.E., and Park B.H. The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol. Ther. 3 (2004) 772-775